Zealand Pharma A/s Stock
€57.20
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -0.310% | 0.246% | -7.508% | -39.545% | -10.660% | 107.553% | - |
| Saniona AB | 0.000% | 1.848% | 28.497% | 285.093% | 29.301% | 886.083% | 28.364% |
| Immunic Inc. | -5.430% | 8.235% | 10.843% | -41.214% | 28.372% | -79.279% | -96.344% |
| Ocuphire Pharma Inc. | 3.690% | -13.800% | 20.690% | 96.325% | 20.690% | -37.577% | - |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


